Lgd
Clinical trials sponsored by Lgd, explained in plain language.
-
Could a simple supplement ease sickle cell symptoms?
Disease control CompletedThis study tested a nutraceutical supplement called NUV001 in 168 adults with sickle cell disease. Participants took either an immediate-release or gastro-resistant version of NUV001, or a placebo, daily for 90 days. The main goal was to check safety and tolerability, with early …
Phase: NA • Sponsor: LGD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New supplement shows promise for sickle cell sufferers in early trial
Symptom relief CompletedThis study tested a daily dietary supplement called NUV001 in 12 adults with sickle cell disease (SS type) over 120 days. The main goals were to see if it is safe and tolerable, and to measure its effects on blood health and quality of life. Researchers tracked side effects, hosp…
Phase: NA • Sponsor: LGD • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC